Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Nursing Management
|
May 7, 2009
Improving patient safety: an economic perspective on the role of nurses
Rebecca N Warburton
BMJ (Clinical Research Ed.)
|
December 4, 2003
What do we gain from the sixth coronary heart disease drug?
Rebecca N Warburton
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services
|
December 13, 2005
Preliminary outcomes and cost-benefit analysis of a community hospital emergency department screening and referral program for patients aged 75 or more
Rebecca N Warburton
Journal of Health Economics
|
August 10, 2005
Extraordinary claims require extraordinary evidence
Donald W Light, Rebecca N Warburton
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services
|
November 24, 2004
Identification of seniors at risk: process evaluation of a screening and referral program for patients aged > or =75 in a community hospital emergency department
Rebecca N Warburton, Belinda Parke, Wynona Church, et al.
Vaccine
|
August 12, 2009
Estimated research and development costs of rotavirus vaccines
Donald W Light, Jon Kim Andrus, Rebecca N Warburton
Vaccine
|
October 25, 2016
Manufacturing costs of HPV vaccines for developing countries
Chaevia Clendinen, Yapei Zhang, Rebecca N Warburton, et al.
BMC Geriatrics
|
November 24, 2022
The Revised Identification of Seniors At Risk screening tool predicts readmission in older hospitalized patients: a cohort study
Jane McCusker, Rebecca N Warburton, Sylvie D Lambert, et al.
The American Journal of Cardiology
|
May 12, 2004
Comparison of treatment outcomes in patients > or =80 years undergoing transradial versus transfemoral coronary intervention
W Peter Klinke, J David Hilton, Rebecca N Warburton, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Nursing Management
|
May 7, 2009
Improving patient safety: an economic perspective on the role of nurses
Rebecca N Warburton
BMJ (Clinical Research Ed.)
|
December 4, 2003
What do we gain from the sixth coronary heart disease drug?
Rebecca N Warburton
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services
|
December 13, 2005
Preliminary outcomes and cost-benefit analysis of a community hospital emergency department screening and referral program for patients aged 75 or more
Rebecca N Warburton
Journal of Health Economics
|
August 10, 2005
Extraordinary claims require extraordinary evidence
Donald W Light, Rebecca N Warburton
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services
|
November 24, 2004
Identification of seniors at risk: process evaluation of a screening and referral program for patients aged > or =75 in a community hospital emergency department
Rebecca N Warburton, Belinda Parke, Wynona Church, et al.
Vaccine
|
August 12, 2009
Estimated research and development costs of rotavirus vaccines
Donald W Light, Jon Kim Andrus, Rebecca N Warburton
Vaccine
|
October 25, 2016
Manufacturing costs of HPV vaccines for developing countries
Chaevia Clendinen, Yapei Zhang, Rebecca N Warburton, et al.
BMC Geriatrics
|
November 24, 2022
The Revised Identification of Seniors At Risk screening tool predicts readmission in older hospitalized patients: a cohort study
Jane McCusker, Rebecca N Warburton, Sylvie D Lambert, et al.
The American Journal of Cardiology
|
May 12, 2004
Comparison of treatment outcomes in patients > or =80 years undergoing transradial versus transfemoral coronary intervention
W Peter Klinke, J David Hilton, Rebecca N Warburton, et al.
Page
of 1